Subscribe to RSS Feed
e-2200 (Cannabis)
E-petition
Initiated by Melissa Ciraco from Fergus, Ontario
Original language of petition: English
Petition to the House of Commons
Whereas:
- In 2018, the Federal Cannabis Act was created, classifying all phytocannabinoids as Schedule 1 substances under this Act, including Cannabidiol (CBD), derived from either Cannabis or Industrial Hemp plants;
- The current Industrial Hemp Regulations impose limitations to processing the whole hemp plant, allowing derivatives only to be extracted from the hemp seed, restricting CBD extracted from hemp;
- CBD is non-psychoactive and was addressed by the World Health Organization which stated that CBD exhibits no effects indicative of any abuse or dependence potential; and
- CBD is currently being used by Canadians, non-recreationally, to help with symptoms of disorders such as: anxiety/mood, chronic pain/inflammation, seizures, and other conditions.
We, the undersigned, Citizens of Canada, call upon the Government of Canada to: (a) reclassify Cannabidiol (CBD) within the Federal Cannabis Act (S.C. 2018, c. 16) from Schedule I; (b) remove restrictions towards harvesting and activities with whole Industrial Hemp plants, including sprouts, leaves, flowers, or bracts of those plants within the Industrial Hemp Regulations (SOR/2018-145); (c) allow derivatives from whole/partial Industrial Hemp with less than 0.3% tetrahydrocannabinol (THC) concentration to be exempt for the purpose of importation, exportation, wholesale, and retail with appropriate restrictions (i) testing at a competent laboratory using a validated test method on a representative sample from each lot/batch, (ii) providing a Certificate of Analysis with each shipment, (iii) labelling products and shipping containers with “contains less than 0.3% THC”; and (d) help alleviate pain and suffering by allowing Canadians access to hemp-derived CBD products.
- Open for signature
- May 22, 2019, at 2:56 p.m. (EDT)
- Closed for signature
- July 21, 2019, at 2:56 p.m. (EDT)
